1 |
赵平,陈万青.2010中国肿瘤登记年报[M].北京:军事医学科学出版社,2010.
|
2 |
Rim S H, Seeff L, Ahmed F,et al.Colorectal cancer incidence in the United States,1999-2004:An updated analysis of data from the National Program of Cancer Registries and the Surveillance,Epidemiology,and End Results Program[J].Cancer,2009,115(9):1967-1976.
|
3 |
Johns LE, Houlston RS.A systematic review and meta-analysis of familial prostate cancer risk[J].Bju International,2015,91(9):789-794.
|
4 |
Chen H M, Weng Y R, Jiang B,et al.Epidemiological study of colorectal adenoma and cancer in symptomatic patients in China between 1990 and 2009[J].J Dig Dis,2011,12(5):371-378.
|
5 |
O′Hare A, Fenlon H.Virtual colonoscopy in the detection of colonic polyps and neoplasms[J].Best Pract Res Clin Gastroenterol,2006,20(1):79-92.
|
6 |
Gutfeld, O.Expression of Serum Amyloid A,in Normal,Dysplastic,and Neoplastic Human Colonic Mucosa:Implication for a Role in Colonic Tumorigenesis[J].J Histochem Cytochemistry,2006,54(1):63-73.
|
7 |
Sherwood RA.Faecal markers of gastrointestinal inflammation[J].J Clin Pathol,2012,65(11):981-985.
|
8 |
Magdalena KM, MaGorzata W, Eugeniusz JK.Calprotectin in rheumatic diseases:a review[J].Reumatologia/Rheumatology,2016,6:306-309.
|
9 |
Roseth AG, Schmidt PN, Fagerhol MK.Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin,a granulocyte marker protein,in patients with inflammatory bowel disease[J].Scand J Gastroenterol,1999,34:50-54.
|
10 |
Tibble J.A simple method for assessing intestinal inflammation in Crohn\" s disease[J].Gut,2000,47(4):506-513.
|
11 |
Tibble JA, Bjarnason I.Non-invasive investigation of inflammatory bowel disease[J].World J Gastroenterol,2001,7(4):460-465.
|
12 |
Vogl T, Tenbrock K, Ludwig S,et al.Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4,promoting lethal,endotoxin-induced shock[J].Nature Medicine,2007,13(9):1042-1049.
|
13 |
Ayling RM, Kok K.Fecal Calprotectin[J].Adv Clin Chem,2018,87:161-190.
|
14 |
Dhaliwal A, Zeino Z, Tomkins C,et al.Utility of faecal calprotectin in inflammatory bowel disease(IBD):what cut-offs should we apply?[J].Frontline Gastroenterology,2015,6(1):14-19.
|
15 |
Lasson A, Stotzer P O, Öhman, Lena,et al.The intra-individual variability of faecal calprotectin:A prospective study in patients with active ulcerative colitis[J].J Crohns Colitis,2015,9(1):26-32.
|
16 |
Dhaliwal A, Zeino Z, Tomkins C,et al.Utility of fecal calprotectin in inflammatory bowel disease(IBD):what cut-offs should we apply?[J].Frontline Gastroenterology,2015,6(1):14-19.
|
17 |
Ricciuto A.Clinical value of fecal calprotectin.Crit Rev Clin Lab Sci,2019,56:307-320.
|
18 |
Coorevits L, Baert FJ, Vanpoucke HJM.Fecal calprotectin:comparative study of the Quantum Blue rapid test and an established ELISA method[J].Clinical Chemistry and Laboratory Medicine,2013,51(4):825-831.
|
19 |
Labaere D, Smismans A, Van Olmen A,et al.Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease[J].United European Gastroenterology Journal,2014,2(1):30-37.
|
20 |
Kaiser T, Langhorst J, Wittkowski H,et al.Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome[J].Gut,2007,56(12):1706-1713.
|
21 |
Caviglia GP, Pantaleoni S, Touscoz GA,et al.Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders[J].Scand J Gastroenterol,2014,49(12):1419-1424.
|
22 |
Caviglia GP, Ribaldone DG, Rosso C,et al.Fecal calprotectin:beyond intestinal organic diseases[J].Panminerva Med,2018,60(1):29-34.
|
23 |
Pezzilli R, Barassi A, Labate A MM,et al.Fecal Calprotectin Levels in Patients with Colonic Polyposis[J].Dig Dis Scis,2008,53(1):47-51.
|
24 |
Tibble J.Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma[J].Gut,2001,49(3):402-408.
|
25 |
杨洁.粪便钙卫蛋白检测在结直肠癌诊断中的作用探究[J].检验医学与临床,2016,13(14):1972-1974.
|
26 |
Luley K, Noack F, Lehnert H,et al.Local calprotectin production in colorectal cancer and polyps-active neutrophil recruitment in carcinogenesis[J].Int J Colorectal Dis,2011,26(5):603-607.
|
27 |
Damms A, Bischoff SC.Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases[J].Intl J Colorectal Dis,2008,23(10):985-992.
|
28 |
Fox V L, Perros S, Jiang H,et al.Juvenile polyps:recurrence in patients with multiple and solitary polyps.[J].Clin Gastroenterol Hepatol,2010,8(9):795-799.
|
29 |
Pauley-Hunter RJ, Kunnath S, Wolff K,et al.Fecal Calprotectin and Pediatric Juvenile Polyps[J].J Pediatr Gastroenterol Nutr,2015,60(4):30-1.
|
30 |
Olafsdottir I, Nemeth A, Lörinc, Ester,et al.Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy[J].J Pediatr Gastroenterol Nutr,2016,62(1):43.
|
31 |
Hodgson-Parnell L, Spence O.Solitary juvenile polyp as a cause of elevated faecal calprotectin in an adult[J].BMJ Case Rep,2018,2018.
|